Ahmed Hamouda is the Head of Clinical Operations in the Middle East and Africa at RAY. In more than 10 years in the clinical research field, Ahmed has worked on both the CRO side and the pharmaceutical side in Europe, the Middle East, the Far East, and Africa.
Ahmed brings the full range of his experience to bear at RAY, which provides outsourcing and consulting services to support pharmaceutical and biotech companies through the clinical trial development process. With RAY, Ahmed leverages his expertise to bring hope and opportunity to patient populations who would not otherwise be reached.
Episode Highlights
Why Africa and Middle Eastern markets represent a major opportunity for sponsors
What regulations and unique requirements sponsors need to understand before moving into these markets
How the site selection and preparation process is different in these markets as opposed to in the U.S.
The importance of partnering with qualified regional experts
The challenges involved in driving patient participation in these regions
How one rare disease clinical trial was saved by a move from the U.S. to the Middle East, and how that move paid off in terms of recruitment
Potential logistical issues with global trials and how RAY manages them
Why continuous education is so important for sites
How Ahmed and RAY estimate the timeframe for study startup in a new region
The unexpected positive regional outcomes of the pandemic
Podden och tillhörande omslagsbild på den här sidan tillhör
ArcheMedx Inc.. Innehållet i podden är skapat av ArcheMedx Inc. och inte av,
eller tillsammans med, Poddtoppen.
